Pharmaceutical companies increase drug prices: WSJ Report
More and more pharmaceutical companies are reportedly buying drugs from rivals and raising the price.
Advertisement
Recommended Stories
Forget Nvidia: Members of Congress Are Scooping Up Shares of Its Core Rival Instead
There's a much more popular AI stock on Capitol Hill than the leading AI chip maker.
Motley Fool•Are You Saving Enough To Be In The Top 3% Of Retirees? Here's How Much You Need
Retirement savings play a crucial role in securing financial stability in your golden years. For those aiming high, being in the top 3% of retirees in terms of savings enhances comfort and offers greater financial freedom. Using data from the Federal Reserve's Survey of Consumer Finances, a 2024 survey by the Employee Benefit Research Institute, reveals that individuals with over $1 million in retirement accounts rank in the top 3% of retirees. Only 3.2% of retirees have surpassed the $1 million
Benzinga•Nvidia Owns a 3.4% Stake in This Innovative Artificial Intelligence (AI) Stock Cathie Wood Loves
The $50 million purchase could turn into Nvidia's biggest investment.
Motley Fool•2 Stock-Split Stocks to Buy Hand Over Fist Right Now
These proven wealth builders could be exactly what you're searching for right now.
Motley Fool•3 Stocks to Invest $30,000 in Right Now
$10,000 to each of these companies could deliver major returns over the next decade.
Motley Fool•Generative AI Software Sales Could Soar 6,260%: My Pick for the Best AI Stock to Buy Now (Hint: Not Nvidia)
This little-known software stock could soar as businesses spend more on generative artificial intelligence.
Motley Fool•Housing supply surges by up to 50% in these metro areas — and many sellers are being forced to slash their asking prices
The property report includes 85 major metropolitan areas in the U.S. with populations of at least 750,000.
MarketWatch•3 Dividend Stocks to Buy and Hold for the Next Decade
You'll get dividends and more with these great stocks.
Motley Fool•This Is the Average Social Security Benefit for Age 67
The number probably isn't anywhere near what you think it is.
Motley Fool•Worried About a Stock Market Sell-Off? Buy This Top Vanguard ETF
There are benefits to investing in stocks that have reasonable multiples and aren't as dependent on future earnings growth to justify their valuations.
Motley Fool•